Revatis

In 2023, the Equine care Group entered into a partnership with REVATIS, a Belgian high-tech laboratory specialized in stem cell technology.

About Revatis: a Spin Off from the University of Liège, dedicated to regenerative medicine and cell therapy. Revatis is based on the scientific discoveries of Prof. D. Serteyn and Dr J. Ceusters and has solid intellectual property and exceptional know-how. Revatis has a patented technology for obtaining multipotent stem cells from a muscle micro-biopsy. This technology is available for clinical applications in veterinary medicine and for research in human medicine.

Revatis aims to produce autologous stem cells for therapeutic use in horses and companion animals. In human medicine, Revatis is positioning itself as a supplier of personalized stem cells for banking, research, organ-on-a-chip and 3D bioprinting.

Revatis bridges the gap between research and clinical uses of cell therapy and regenerative medicine.

• R&D centers in cell therapy
• Companies dedicated to 3D bioprinting
• Companies dedicated to organs on a chip
• Veterinarians
• Specialist clinicians
• Breeders
• Owners
• Trainers
• Riders